Adjunctive ibuprofen in pre-extensively drug-resistant and extensively drug-resistant tuberculosis: a phase IIA open-label pilot clinical trial

Kaori L. Fonseca, Judith Farrés, Ketevan Barbakadze, Iza Jikia, Malkhaz Tsotskhalashvili, Juan M. García-Illarramendi, Lilibeth Arias, Kennedy Otwombe, Chiara Sopegno, Albert Despuig, Neil Martinson, Nadiia Buhiichyk, Tamta Korinteli, Émilie Layre, Jérôme Nigou, Zaza Avaliani, Nestani Tukvadze, Sergo Vashakidze, Cristina Vilaplana

Open source

DOI: 10.1038/s41467-026-75148-9
Published: 2026-07-01
Container: Nature Communications
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-026-75148-9,
  title = {Adjunctive ibuprofen in pre-extensively drug-resistant and extensively drug-resistant tuberculosis: a phase IIA open-label pilot clinical trial},
  author = {Kaori L. Fonseca and Judith Farrés and Ketevan Barbakadze and Iza Jikia and Malkhaz Tsotskhalashvili and Juan M. García-Illarramendi and Lilibeth Arias and Kennedy Otwombe and Chiara Sopegno and Albert Despuig and Neil Martinson and Nadiia Buhiichyk and Tamta Korinteli and Émilie Layre and Jérôme Nigou and Zaza Avaliani and Nestani Tukvadze and Sergo Vashakidze and Cristina Vilaplana},
  year = {2026},
  journal = {Nature Communications},
  doi = {10.1038/s41467-026-75148-9},
  url = {https://doi.org/10.1038/s41467-026-75148-9}
}

RIS

TY  - JOUR
TI  - Adjunctive ibuprofen in pre-extensively drug-resistant and extensively drug-resistant tuberculosis: a phase IIA open-label pilot clinical trial
AU  - Kaori L. Fonseca
AU  - Judith Farrés
AU  - Ketevan Barbakadze
AU  - Iza Jikia
AU  - Malkhaz Tsotskhalashvili
AU  - Juan M. García-Illarramendi
AU  - Lilibeth Arias
AU  - Kennedy Otwombe
AU  - Chiara Sopegno
AU  - Albert Despuig
AU  - Neil Martinson
AU  - Nadiia Buhiichyk
AU  - Tamta Korinteli
AU  - Émilie Layre
AU  - Jérôme Nigou
AU  - Zaza Avaliani
AU  - Nestani Tukvadze
AU  - Sergo Vashakidze
AU  - Cristina Vilaplana
PY  - 2026
JO  - Nature Communications
DO  - 10.1038/s41467-026-75148-9
UR  - https://doi.org/10.1038/s41467-026-75148-9
ER  -

APA

Fonseca, K. L., Farrés, J., Barbakadze, K., Jikia, I., Tsotskhalashvili, M., García-Illarramendi, J. M., Arias, L., Otwombe, K., Sopegno, C., Despuig, A., Martinson, N., Buhiichyk, N., Korinteli, T., Layre, É., Nigou, J., Avaliani, Z., Tukvadze, N., Vashakidze, S., & Vilaplana, C. (2026). Adjunctive ibuprofen in pre-extensively drug-resistant and extensively drug-resistant tuberculosis: a phase IIA open-label pilot clinical trial. Nature Communications. https://doi.org/10.1038/s41467-026-75148-9

Source records

crossref · retrieved 2026-09-26T02:46:15.018Z